Gd Searle patents expiration
1. Bextra patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5633272 | GD SEARLE | Substituted isoxazoles for the treatment of inflammation |
Feb, 2015
(9 years ago) | |
Drugs and Companies using VALDECOXIB ingredient
Market Authorisation Date: 16 November, 2001
Treatment: Signs and symptoms of osteoarthritis and adult rheumatoid arthritis and treatment of primary dysmenorrhea
Dosage: TABLET;ORAL
More Information on Dosage
BEXTRA family patents
